Normal diploid IMR90 human fibroblasts were cultured according to the ATCC in low oxygen (2% O2) in DMEM (4.5 g/L glucose, Corning cat# 10-017-CV) with 10% FBS supplemented with L-glutamine, non-essential amino acids, sodium pyruvate, and sodium bicarbonate. Experiments were performed on IMR90 between population doubling #25–35. Melanoma (SKMel28), pancreatic (PATU8902), colorectal (HT-29, SW620, and SW480) tumor cells and lentiviral and retroviral packaging cells (293FT and Phoenix, respectively) were cultured in DMEM (Corning, cat# 10–013-CV) with 10% FBS. ES2 ovary tumor cell line was cultured in RPMI 1640 with 10% FBS. TCCSUP bladder cancer cell line was cultured in MEM/EBSS glutamine supplemented with 10% FBS. All cell lines were cultured in MycoZap and were routinely tested for mycoplasma as described in Uphoff and Drexler (2005). All tumor cell lines included in this work express wild-type CDKN2A according to TCGA (Cerami et al., 2012; Gao et al., 2013). According to ATCC, TCCSUP harbors a mutation in RB1. All cell lines were authenticated using STR Profiling (Genetica DNA Laboratories).
Two-month old male SCID mice were purchased from Charles River Laboratories. All mice were maintained in a HEPA-filtered ventilated rack system at the Penn State College of Medicine animal facility. Mice were housed up to 5 mice per cage and in a 12-hour light/dark cycle. All experiments with animals were performed in accordance with institutional guidelines approved by the Institutional Animal Care and Use Committee (IACUC) at the Penn State College of Medicine.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.